Gautam Khanna, analyst at TD Cowen, shares his outlook for Boeing and says it will take "a number of years" before the ...

In a report released today, Andrew Kligerman from TD Cowen maintained a Hold rating on Progressive (PGR – Research Report), with a price target ...

Pembina Pipeline (NYSE:PBA) +0.5% in Wednesday's trading as analysts at TD Cowen call the stock its top pick for Canadian ...

Investing.com -- TD Cowen initiated coverage of ConocoPhillips (NYSE: COP) with a "Buy" rating and a $125 price target, ...

TD Cowen analyst Bryan Bergin raised the firm’s price target on ADP (ADP) to $290 from $285 and keeps a Hold rating on the shares as part of a ...

TD Cowen analysts estimate that about 45% of U.S. sales for Ozempic and Rybelsus each goes through Medicare Part D.

With a finite number of carriers in most regions, the LTL industry is much more disciplined on pricing than the highly ...

TD Cowen initiated coverage of Centessa (CNTA) with a Buy rating and no price target The firm says the company’s ORX750 has a “best in class profile as a transformative therapy” in excessive ...

On Monday, Jan. 7, Michael Lavery at Piper Sandler initiated coverage of the beverage giant, with an overweight rating and a ...

TD Cowen analyst Tyler Van Buren initiated coverage of CG Oncology (CGON) with a Buy rating and no price target The firm says cretostimogene is differentiated by its “superior” efficacy and ...

Pembina Pipeline (NYSE:PBA) +0.5% in Wednesday's trading as analysts at TD Cowen call the stock its top pick for Canadian midstream exposure, believing the company features the sector's best ...